World Lung Cancer Day

United States, Canada, United Kingdom, Australia, New Zealand, India, China, Japan, South Korea, Singapore, Malaysia, Thailand, Philippines, Indonesia, South Africa, Nigeria, Kenya, Germany, France, Italy, Spain, Netherlands, Sweden, Norway, Denmark, Brazil, Mexico, Argentina, Colombia, Chile

About

World Lung Cancer Day, observed on August 1, raises awareness about lung cancer and its impact on individuals, families, and communities worldwide. The day encourages people to learn about risk factors, warning signs, prevention, early detection, and the importance of seeking medical guidance.

It is also an opportunity to support those living with lung cancer, remember those who have died from the disease, and recognize the dedication of caregivers, researchers, and healthcare professionals. By promoting open conversations and sharing reliable information, World Lung Cancer Day helps foster compassion, reduce stigma, and inspire continued progress in prevention, treatment, and research.

History

World Lung Cancer Day is observed annually on **August 1** to raise awareness of lung cancer, its risk factors, symptoms, prevention, and treatment. The observance emerged from cooperation among international respiratory and cancer organizations, including the Forum of International Respiratory Societies (FIRS) and the International Association for the Study of Lung Cancer (IASLC). Its creation reflected the need for a dedicated occasion to focus public attention on a disease that has long been among the world’s most commonly diagnosed and deadliest cancers.

In its early years, the observance concentrated heavily on tobacco use, the leading preventable cause of lung cancer. Public-health campaigns connected with August 1 encouraged smoking cessation, highlighted the dangers of secondhand smoke, and promoted policies designed to reduce tobacco exposure. Over time, the message broadened to recognize additional contributors, including exposure to radon, asbestos, air pollution, and certain workplace hazards. This wider approach also helped emphasize that lung cancer can affect people who have never smoked.

The observance has evolved alongside advances in medical knowledge. Awareness efforts now commonly discuss early detection, eligibility for screening, genetic and molecular testing, targeted therapies, immunotherapy, and the importance of access to specialist care. August 1 also provides an opportunity for medical institutions, advocacy groups, and public-health organizations to share educational materials, support patients and caregivers, and draw attention to continuing inequalities in diagnosis and treatment.

Culturally, World Lung Cancer Day has helped challenge the stigma that often surrounds lung cancer because of its association with smoking. By presenting lung cancer as a complex disease with multiple causes—and by recognizing the experiences of survivors, families, researchers, and healthcare professionals—the observance encourages compassion as well as prevention. Its continuing significance lies in linking personal stories with broader goals: reducing avoidable risk, improving research and treatment, supporting those affected, and ensuring that lung cancer receives sustained global attention.

Timeline

1950
Richard Doll and Austin Bradford Hill published a landmark British Medical Journal study finding a strong association between cigarette smoking and lung cancer.
1964
The U.S. Surgeon General released Smoking and Health, concluding that cigarette smoking was a cause of lung cancer in men and a probable cause in women.
2011
The National Lung Screening Trial reported that annual low-dose CT screening reduced lung-cancer mortality by 20% among high-risk current and former smokers compared with chest radiography.
2013
The U.S. Preventive Services Task Force issued its first recommendation for annual low-dose CT screening for adults at high risk for lung cancer based on age and smoking history.
2015
The U.S. Food and Drug Administration approved pembrolizumab for certain patients with advanced non-small cell lung cancer whose tumors expressed PD-L1, marking a major immunotherapy milestone.

Upcoming dates

Sources

Same day

Related